• DDI2–NFE2L1 Signaling Protects Against Ferroptosis

  2026-09-30

  The reference study identifies DDI2-dependent activation of NFE2L1 as an adaptive proteostasis pathway that helps cells withstand ferroptosis. Its combination of ubiquitylation proteomics, genetic perturbation, and pharmacological testing shows how disrupting this axis reduces proteasome activity and sensitizes cells to ferroptotic death.

• AMG 9810: TRPV1 Signaling Under Metabolic Stress

  2026-09-30

  AMG 9810 is a selective TRPV1 antagonist for separating sensory calcium signaling from broader metabolic-stress responses. This article develops a compartment-aware assay framework linking TRPV1 perturbation with the AMPK–SQSTM1 findings reported in Autophagy while maintaining clear boundaries between established evidence and exploratory interpretation.

• Mestranol-Induced Lysosomal Stress in Zebrafish Microglia

  2026-09-29

  The reference study establishes mestranol as a pharmacological trigger of a reversible lysosomal storage–like state in zebrafish microglia, without increasing microglial loss or neuronal apoptosis. By combining live imaging, cargo-processing assays, transcriptomics, and TFEC rescue experiments, it separates impaired intracellular digestion from defective phagocytic uptake and provides a tractable model of environmental estrogen-associated neuroimmunotoxicity.

• Baicalin Methyl Ester and Intestinal Barrier Protection

  2026-09-29

  The 2024 Biomedicine & Pharmacotherapy study shows that baicalin methyl ester protects against LPS-induced intestinal barrier injury in mice and MODE-K epithelial cells. Its central contribution is the integration of inflammatory signaling, myosin light chain kinase activity, and tight-junction remodeling into a P65/TNF-α/MLCK/ZO-1 mechanism supported by tissue analysis, protein assays, docking, and immunoprecipitation.

• PML-HIF1AN Control of BMSC Osteogenesis

  2026-09-28

  This 2025 study identifies PML as an upstream regulator of bone marrow mesenchymal stem cell osteogenic differentiation through HIF1AN ubiquitination, HIF1α-dependent SOD3 transcription, and PI3K/AKT signaling. Its integrated use of co-immunoprecipitation, chromatin immunoprecipitation, reporter assays, staining, and pathway inhibition provides a mechanistic framework for studying impaired bone formation.

• Exemestane: From Enzyme Mechanism to Translation

  2026-09-28

  Exemestane offers translational researchers a way to interrogate estrogen production at its enzymatic source. This article connects its irreversible aromatase mechanism with practical assay design, model selection, and the distinct role of receptor-directed endocrine strategies.

• PML–HIF1AN Signaling in BMSC Osteogenesis

  2026-09-27

  This study links PML-dependent HIF1AN ubiquitination to HIF1α/SOD3 signaling and PI3K/AKT activity during bone marrow mesenchymal stem cell osteogenic differentiation. Its combination of interaction, transcriptional, and differentiation assays supports a testable pathway model, while leaving important questions for in vivo validation and mechanistic follow-up.

• GSK 2837808A: Testing the Lactate–PD-L1 Link

  2026-09-26

  GSK 2837808A is a potent lactate dehydrogenase A inhibitor for probing how tumor lactate production relates to immune signaling. This article explains how to use LDHA inhibition to test—not assume—the connection between glycolytic flux and PD-L1 stability in cancer metabolism research.

• From Co-IP to Mechanism: Mapping PINK1 SUMOylation

  2026-09-25

  A mechanistic study links UBC9-mediated PINK1 SUMOylation with mitophagy and oxidative stress in Parkinson’s disease models. Here, we examine what co-immunoprecipitation can establish, how to design stronger interaction experiments, and where the Protein A/G Magnetic Co-IP/IP Kit can support translational research.

• Bacitracin (B1670): Research Workflow Guide

  2026-09-25

  Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research on bacterial growth and cell-wall-related effects. Use it to plan and evaluate laboratory assays—not for diagnostic, clinical, or medical purposes—and confirm activity under the conditions and with the organisms used in your own workflow.

• Hexamethonium Bromide for Autonomic Causality

  2026-09-24

  Hexamethonium Bromide helps researchers probe how autonomic ganglionic transmission contributes to cardiovascular phenotypes. This article explains how to interpret ganglionic blockade as a causal experiment, using sex-dependent angiotensin II hypertension research to clarify the method’s value and limits.

• 3-Deazaneplanocin (DZNep): A Practical Research Guide

  2026-09-24

  Use DZNep to probe SAHH-linked epigenetic effects, apoptosis in AML models, and sphere-forming phenotypes in hepatocellular carcinoma research. A dose-and-time workflow, orthogonal readouts, and receptor-aware experimental design help distinguish model-specific responses from general toxicity.

• Annexin V-Cy5 Apoptosis Kit for Microglia Studies

  2026-09-23

  Pair a fast phosphatidylserine readout with lysosomal measurements to distinguish apoptosis from microglial lysosomal stress. This workflow shows how Cy5 microscopy and flow cytometry can complement a reversible zebrafish model without treating Annexin V signal as a stand-alone measure of cell fate.

• A Multimodal iPSC Platform for Cystic Fibrosis

  2026-09-23

  Berical and colleagues developed a patient-derived iPSC airway platform that connects CFTR genotype with functional phenotypes and drug responses in both three-dimensional spheroids and polarized mucociliary cultures. The study supports iPSC-derived airway cells as a complementary preclinical system, particularly for evaluating rare CFTR variants that are poorly represented in conventional models.

• Puromycin aminonucleoside: Reliable Injury Models

  2026-09-22

  This scenario-based guide explains how Puromycin aminonucleoside (SKU A3740) can improve experimental control in podocyte injury, cytotoxicity, and nephrotic syndrome studies. It covers model selection, preparation, pH-dependent uptake, data interpretation, and practical vendor-selection criteria.

8062 records 1/538 page Next 12345 下5页 Last page